Skip to main content
Equibles

Gil Bloom

Analyst

Needham & Company

Equibles does not estimate personal net worth.

About Gil Bloom

Gil Bloom is recorded as Analyst at Needham & Company. Gil Bloom has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Celcuity Inc. on June 2, 2026. Those appearances were for Celcuity Inc. (CELC), Precision Biosciences Inc (DTIL) and Sarepta Therapeutics, Inc. (SRPT). The companies whose calls Gil Bloom spoke on are classified in the Healthcare sector.

Gil Bloom on recent calls

“Just given where the alpha-lisid plus fulvastrint comparator arm landed, can you remind us of why it may be important to really look closely at the hazard ratios here?”
Analyst — Needham & Company, Phase 3 VIKTORIA-1 PIK3CA Mutant Cohort Clinical Trial Results Conference Call ·
“It is a pleasure to have with me today Precision Biosciences team, Alex Kelly, the Chief Financial Officer, and Cassie Forsuch, the Chief Science Officer. And with that, Alex, feel free to start your presentation.”
Analyst — Needham & Company, 25th Annual Needham Virtual Healthcare Conference ·
“And would any be provided from the ISD that was conducted separately? Thank you.”
Analyst — Needham & Company, Sarepta Therapeutics, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

  • Needham & Company

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity